Treatment of lead poisoning.
D000284:Administration, Oral; D000328:Adult; D000741:Anemia, Aplastic / Q000139:chemically induced; D002614:Chelating Agents / Q000627:therapeutic use*; D002648:Child; D004112:Dimercaprol / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use; D004492:Edetic Acid / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use; D004781:Environmental Exposure; D006801:Humans; D007273:Injections, Intramuscular; D007275:Injections, Intravenous; D007668:Kidney / Q000187:drug effects; D007854:Lead / Q000097:blood; D007855:Lead Poisoning / Q000097:blood / Q000175:diagnosis / Q000188:drug therapy*; D009404:Nephrotic Syndrome / Q000139:chemically induced; D010396:Penicillamine / Q000008:administration & dosage
D002614:Chelating Agents; D004112:Dimercaprol; D007854:Lead; D004492:Edetic Acid; D010396:Penicillamine